DermAbiotech
Plan-les-ouates
About DermAbiotech
DermAbiotech develops innovative targeted therapies for acute T cell-mediated inflammatory diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $9.8K
- Funding stage: Seed
- Last round: Grant (Feb 2016)
Industries & Categories
Biotechnology, Therapeutics
Canonical: https://fsome.com/organization/dermabiotech-2448623 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.